BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16252099)

  • 1. Tissue plasminogen activator for blocked peritoneal dialysis catheters.
    Krishnan RG; Moghal NE
    Pediatr Nephrol; 2006 Feb; 21(2):300. PubMed ID: 16252099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator for occluded peritoneal dialysis catheter.
    Sakarcan A; Stallworth JR
    Pediatr Nephrol; 2002 Mar; 17(3):155-6. PubMed ID: 11956850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator can effectively declot peritoneal dialysis catheters.
    Sahani MM; Mukhtar KN; Boorgu R; Leehey DJ; Popli S; Ing TS
    Am J Kidney Dis; 2000 Sep; 36(3):675. PubMed ID: 10977805
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis catheters and recombinant tissue plasminogen activator.
    Allon M
    N Engl J Med; 2011 May; 364(18):1779; author reply 1779-80. PubMed ID: 21542758
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of tissue plasminogen activator in peritoneal dialysis catheters: a literature review and one center's experience.
    Zorzanello MM; Fleming WJ; Prowant BE
    Nephrol Nurs J; 2004; 31(5):534-7. PubMed ID: 15518255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
    Shea M; Hmiel SP; Beck AM
    Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local fibrinolytic therapy with urokinase for peritoneal dialysis catheter obstruction in children.
    Stadermann MB; Rusthoven E; van de Kar NC; Hendriksen A; Monnens LA; Schröder CH
    Perit Dial Int; 2002; 22(1):84-6. PubMed ID: 11930941
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of tissue plasminogen activator infusion to re-establish function of tunneled hemodialysis catheters.
    Dowling K; Sansivero G; Stainken B; Siskin G; Dolen E; Ahn J; Mitchell N
    Nephrol Nurs J; 2004; 31(2):199-200. PubMed ID: 15114800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing catheter dysfunction for better patient outcomes: a team approach.
    Dinwiddie LC
    Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
    Nguyen TV; Dikun M
    Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of reteplase in poorly functioning hemodialysis catheters.
    Falk A; Samson W; Uribarri J; Vassalotti JA
    Clin Nephrol; 2004 Jan; 61(1):47-53. PubMed ID: 14964457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
    Davies J; Casey J; Li C; Crowe AV; McClelland P
    J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteplase for the treatment of catheter occlusion in pediatric patients.
    Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
    Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance.
    Bamgbola OF; del Rio M; Kaskel FJ; Flynn JT
    Pediatr Nephrol; 2005 Jul; 20(7):989-93. PubMed ID: 15843999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use and complications of three peritoneal dialysis catheter designs. A retrospective analysis.
    Flanigan MJ; Ngheim DD; Schulak JA; Ullrich GE; Freeman RM
    ASAIO Trans; 1987; 33(1):33-8. PubMed ID: 3828160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographically documented fecal impaction causing peritoneal dialysis catheter malfunction.
    Stonehill WH; Smith DP; Noe HN
    J Urol; 1995 Feb; 153(2):445-6. PubMed ID: 7815615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic omentectomy for salvage of peritoneal dialysis catheters.
    Lee M; Donovan JF
    J Endourol; 2002 May; 16(4):241-4. PubMed ID: 12042108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.